Inhibition of SARS-CoV-2 3CL protease by the anti-viral chimeric protein RetroMAD1
COVID-19 results from SARS-CoV-2, which mutates frequently, challenging current treatments. Therefore, it is critical to develop new therapeutic drugs against this disease. This study explores the interaction between SARS-CoV-2 3CLpro and RetroMAD1, a well-characterized coronavirus protein and poten...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | 論文 |
| 出版事項: |
Nature Research
2023
|
| オンライン･アクセス: | http://psasir.upm.edu.my/id/eprint/110356/ https://www.nature.com/articles/s41598-023-47511-z?error=cookies_not_supported&code=c6e450e7-4bbd-44af-ad7c-a9ed05a4a4fe |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|